Value
6.1/10data confidence 100%| Component | Sub-score |
|---|---|
| P/E | 2.4 |
| P/S | 9.8 |
| EV/EBITDA | 0.0 |
| Fwd P/E | 4.8 |
| PEG | 10.0 |
| Analyst target | 7.5 |
- ▸Forward P/E: 26.1x
- ▸PEG: 0.13
BTSG · Why this verdict
Why BrightSpring Health Services, I (BTSG) is rated BUY WAIT
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictBUY WAIT
Overall score5.9/10
ConfidenceMEDIUM
MacroRISK_OFF
TrendMatrix Research · core thesis
Engine thesis — one sentence
The company delivers 26% year-over-year revenue growth with exceptional cash conversion and a consistent earnings beat track record, but the stock has already surpassed its price target and trades within 0.2% of its 52-week high — the reward-to-risk ratio has turned unfavorable and the setup favors trimming rather than adding.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
Revenue is expanding at 26% year-over-year and the company has beaten earnings estimates in three of the last four quarters with an average positive surprise of roughly 13%, demonstrating that operational execution is consistently running ahead of expectations. Growth breakdown | Revenue growth sustains above 20% year-over-year and the earnings beat streak extends to at least 4 of the next 5 quarters, reinforcing the execution narrative. | →Stable |
| CounterHigh headline growth may mask concentration risks — the risk notes flag two material items from annual-report disclosures — and if those concentrated exposures deteriorate, the growth rate could reverse quickly. | ||
Free cash flow is running at 327% of net income, a ratio indicating the business generates substantially more cash than reported earnings imply — a genuine quality backstop beneath the growth story that reduces the risk of an earnings-quality surprise. Quality breakdown | Free cash flow to net income ratio remains above 150% over the next four quarters, confirming the cash generation is structural rather than a one-period anomaly. | →Stable |
| CounterAn FCF-to-net-income ratio far above 100% can reflect accounting differences such as non-cash charges inflating cash flow; without a competitive moat to protect margins, this conversion rate may not persist through a business cycle. | ||
The current price has moved above the price target, leaving negative headroom to the upside level — the stock has already realized the anticipated move, and the reward-to-risk ratio has turned unfavorable with more downside than upside at this entry. Price targets | This pillar is falsified if the analyst consensus price target is revised upward such that upside from the current price exceeds 15%, re-establishing a positive risk/reward. | ↑Improving |
| CounterStocks frequently trade through near-term price targets during strong momentum phases; the 26% growth trajectory and strong cash conversion could support a higher fundamental valuation than the current target captures. | ||
A leverage ratio that has triggered a penalty, no identifiable competitive moat, and a below-average quality score together raise the question of whether high growth is being funded in a way that limits long-term compounding power and increases downside risk if growth slows. Bear case | This pillar is falsified if the debt-to-equity ratio declines by more than 20% from current levels over four consecutive quarters while the quality score rises above 5.0. | ↑Improving |
| CounterEarly-phase growth businesses often carry higher leverage as a deliberate choice to fund expansion; if the 26% growth rate justifies the borrowing cost, current leverage could reflect disciplined capital allocation rather than financial fragility. | ||
Revenue is expanding at 26% year-over-year and the company has beaten earnings estimates in three of the last four quarters with an average positive surprise of roughly 13%, demonstrating that operational execution is consistently running ahead of expectations.
→StableGrowth breakdown
- Expectation
- Revenue growth sustains above 20% year-over-year and the earnings beat streak extends to at least 4 of the next 5 quarters, reinforcing the execution narrative.
CounterHigh headline growth may mask concentration risks — the risk notes flag two material items from annual-report disclosures — and if those concentrated exposures deteriorate, the growth rate could reverse quickly.
Free cash flow is running at 327% of net income, a ratio indicating the business generates substantially more cash than reported earnings imply — a genuine quality backstop beneath the growth story that reduces the risk of an earnings-quality surprise.
→StableQuality breakdown
- Expectation
- Free cash flow to net income ratio remains above 150% over the next four quarters, confirming the cash generation is structural rather than a one-period anomaly.
CounterAn FCF-to-net-income ratio far above 100% can reflect accounting differences such as non-cash charges inflating cash flow; without a competitive moat to protect margins, this conversion rate may not persist through a business cycle.
The current price has moved above the price target, leaving negative headroom to the upside level — the stock has already realized the anticipated move, and the reward-to-risk ratio has turned unfavorable with more downside than upside at this entry.
↑ImprovingPrice targets
- Expectation
- This pillar is falsified if the analyst consensus price target is revised upward such that upside from the current price exceeds 15%, re-establishing a positive risk/reward.
CounterStocks frequently trade through near-term price targets during strong momentum phases; the 26% growth trajectory and strong cash conversion could support a higher fundamental valuation than the current target captures.
A leverage ratio that has triggered a penalty, no identifiable competitive moat, and a below-average quality score together raise the question of whether high growth is being funded in a way that limits long-term compounding power and increases downside risk if growth slows.
↑ImprovingBear case
- Expectation
- This pillar is falsified if the debt-to-equity ratio declines by more than 20% from current levels over four consecutive quarters while the quality score rises above 5.0.
CounterEarly-phase growth businesses often carry higher leverage as a deliberate choice to fund expansion; if the 26% growth rate justifies the borrowing cost, current leverage could reflect disciplined capital allocation rather than financial fragility.
Per-dimension breakdown
Quality
4.4/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 4.3 |
| ROA | 3.3 |
| Gross margin | 0.0 |
| Op margin | 1.3 |
| Net margin | 1.3 |
| Current ratio | 5.8 |
| FCF quality | 10.0 |
| Moat | 5.4 |
| Piotroski F | 7.8 |
- ▸Excellent cash conversion: 281% FCF/NI
- ▸No competitive moat
- ▸Strong Piotroski F-Score: 7/9
Growth
9.1/10data confidence 67%| Component | Sub-score |
|---|---|
| Rev growth | 8.2 |
| EPS growth | 10.0 |
- ▸Strong growth: 23% YoY
Momentum
3.0/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 8.1 |
| MACD | 0.0 |
| OBV | 1.0 |
| MA position | 6.0 |
| Volume | 0.0 |
- ▸Uptrend pullback (RSI 34) - buy opportunity
- ▸Volume distribution (falling OBV)
- ▸Above 200-day MA
Sentiment
7.7/10data confidence 100%| Component | Sub-score |
|---|---|
| Analyst rating | 8.8 |
| Price target | 8.7 |
| erm sentiment | 5.0 |
- ▸Analyst upside: 31%
Insider
4.5/10data confidence 50%| Component | Sub-score |
|---|---|
| holder change | 3.9 |
| notable moves | 5.0 |
- ▸Insider dollar basis unavailable — not scored
Peer rank
5.2/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 6.0 |
| quality rank | 6.6 |
| growth rank | 7.3 |
Technical
6.9/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 7.3 |
| support resistance | 7.2 |
| 52w position | 6.3 |
Risk (lower is worse)
5.2/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 5.5 |
| days to cover | 5.9 |
| volatility | 5.5 |
| put call | 9.7 |
| implied vol | 1.9 |
| max pain risk | 5.0 |
| beta | 3.7 |
| debt equity | 4.7 |
- ▸High IV: 69%
- ▸Concentration risks: 2 MED (10-K Item 1A)
Catalyst
6.3/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 6.7 |
| earnings timing | 5.0 |
| surprise avg | 8.5 |
- ▸Strong earnings: 3B/1M
- ▸Earnings in 1 day
How the verdict was assembled
Engine trigger
Earnings in 1 day. Wait until post-earnings.
Engine technical detail
verdict_path:
L3:NEWS_BLOCK|ENTRY_STICKY:WITHIN_BANDPassed (5)
- ASYMMETRY:3.3>=1.5
- 8K:CLEAN
- NEWS_EVENTS:NONE_RECENT
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (2)
- MOMENTUM:3.0<4.5
- EARNINGS_PROXIMITY:1d<=7d
Warning (0)
none
Insider data unavailable
Reward-to-Risk
3.26
Upside
+18.2%
Downside
5.6%
Sizing output
STARTER
Setup— — No clear chart pattern; technical signals are mixed
EdgeNo clear edge — No clear edge identified
SuitabilityAggressive — Beta 1.88>1.3
Investment implication
A recent news event triggered an L3 news-block on the verdict path. Trigger: Earnings in 1 day. Wait until post-earnings. The 10-dimension scores remain Growth at 9.1 (strongest), but MOMENTUM:3.0<4.5 also fails — the news block is the proximate trigger, not the sole driver.
The strongest dimensions are Growth at 9.1, Sentiment at 7.7, and Technical at 6.9; the weakest are Momentum at 3.0, Quality at 4.4, and Insider at 4.5. The V9 engine flagged 2 failed gates, producing an asymmetric reward-to-risk of 3.26 and an engine sizing output of STARTER.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Strong Revenue Growth Momentum
Trip ifRevenue growth falls below 15% YoY for 2 consecutive quarters.
- P2Exceptional Cash Conversion
Trip ifFree cash flow to net income ratio falls below 100% for 2 consecutive quarters.
- P3Stock Priced Above Target
Trip ifAnalyst consensus price target is revised upward such that upside from the current price exceeds 15%.
- P4Leverage And Quality Constraints
Trip ifDebt-to-equity ratio declines by more than 20% from current levels over 4 consecutive quarters.